In an unprecedented advancement in cancer treatment, a research team led by Professor Kwang-Hyun Cho from KAIST has developed a groundbreaking technology that targets colon cancer by transforming malignant cells into normal-like cells without killing them. Unlike traditional cancer therapies that
Multiple myeloma (MM), a complex form of blood cancer originating in plasma cells, relentlessly impairs blood counts and immune functions. Despite breakthroughs in treatment modalities, MM largely remains incurable, with patients often enduring cycles of remission interrupted by relapses. This
The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
In recent years, significant advancements have been made in treating pediatric acute lymphocytic leukemia (B-ALL) through combining traditional chemotherapy with innovative drugs like blinatumomab. This blend of treatments, examined in a clinical trial, has shown promising results, particularly in
Teeth play a crucial role in the human body, primarily in breaking down food. They are protected by enamel, which allows them to endure significant stress during chewing. Unlike other bodily materials, enamel lacks the ability to self-repair, making it susceptible to deterioration over time. As
Imagine a world where a simple leaf extract from an ancient tree could offer a safer and more effective treatment for pain and arthritis, potentially revolutionizing how we manage these chronic conditions. This scenario is not far-fetched, thanks to groundbreaking research on the medicinal
